📣 VC round data is live. Check it out!
- Public Comps
- Apyx Medical
Apyx Medical Valuation Multiples
Discover Apyx Medical's revenue and EBITDA valuation multiples and M&A history, alongside public comparables like Edap TMS, Sisram Medical, Inogen, Quanterix and more.
Apyx Medical Overview
About Apyx Medical
Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Advanced Energy and Original Equipment Manufacturing (OEM). Its Advanced Energy segment derives the majority of its revenue.
Founded
1982
HQ

Employees
220
Website
Financials (LTM)
EV
$170M
Valuation Multiples
Start free trialApyx Medical Financials
Apyx Medical reported last 12-month revenue of $56M and negative EBITDA of ($4M).
In the same LTM period, Apyx Medical generated $35M in gross profit, ($4M) in EBITDA losses, and had net loss of ($11M).
Revenue (LTM)
Apyx Medical P&L
In the most recent fiscal year, Apyx Medical reported revenue of $53M and EBITDA of ($4M).
Apyx Medical is unprofitable as of last fiscal year, with gross margin of 63%, EBITDA margin of (7%), and net margin of (21%).
Financial data powered by Morningstar, Inc.
Apyx Medical Stock Performance
Apyx Medical has current market cap of $162M, and enterprise value of $170M.
Market Cap Evolution
Apyx Medical's stock price is $3.86.
Apyx Medical share price decreased by 3.3% in the last 30 days, and increased by 71.8% in the last year.
Apyx Medical has an EPS (earnings per share) of $-0.27.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $170M | $162M | -2.4% | -3.3% | 4.7% | 71.8% | $-0.27 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialApyx Medical Valuation Multiples
Apyx Medical trades at 3.1x EV/Revenue multiple, and (43.5x) EV/EBITDA.
EV / Revenue (LTM)
Apyx Medical Financial Valuation Multiples
As of June 3, 2026, Apyx Medical has market cap of $162M and EV of $170M.
Apyx Medical has a P/E ratio of (14.2x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Apyx Medical Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Apyx Medical Margins & Growth Rates
Apyx Medical grew revenue by 13% and EBITDA by 7% in the last fiscal year.
In the most recent fiscal year, Apyx Medical reported gross margin of 63%, EBITDA margin of (7%), and net margin of (21%).
Apyx Medical Margins
Apyx Medical Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Apyx Medical Operational KPIs
Apyx Medical's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.2M for the same period.
Apyx Medical's Rule of 40 is 6% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Apyx Medical's Rule of X is 25% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Apyx Medical Competitors
Apyx Medical competitors include Edap TMS, Sisram Medical, Inogen, Quanterix, NN, Aroa Biosurgery, EKF Diagnostics, Guerbet, CROSSJECT and Owlet.
Most Apyx Medical public comparables operate across Medical Devices, HealthTech and DeepTech.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| - | 2.5x | - | (7.6x) | |||
| 0.4x | 0.4x | 2.9x | 3.5x | |||
| 0.2x | 0.2x | 26.6x | 25.1x | |||
| 0.7x | 0.7x | (2.3x) | (2.7x) | |||
| 0.9x | 0.8x | 7.5x | 7.1x | |||
| 2.8x | 2.5x | 81.9x | 21.4x | |||
| 2.0x | 1.9x | 8.1x | 7.9x | |||
| 0.5x | 0.6x | 5.0x | 5.0x | |||
This data is available for Pro users. Sign up to see all Apyx Medical competitors and their valuation data. Start Free Trial | ||||||
Acquisitions by Apyx Medical
Apyx Medical has acquired 1 company to date.
Last acquisition by Apyx Medical was on October 20th 2015. Apyx Medical acquired Bovie Bulgaria EOOD for $600K (EV/Revenue multiple available to Pro users).
Latest Acquisitions by Apyx Medical
| Description | Bovie Bulgaria EOOD is a Sofia-based contract manufacturer and research facility for medical devices. It produces electrosurgical generators, electrodes, and cautery tools under ISO 13485 standards for export to Europe and North America. The company supports parent firm Apyx Medical in assembling handheld plasma devices and precision instruments used in minimally invasive surgeries. Bovie Bulgaria conducts R&D on helium-based ablation technologies, scaling production for operating rooms and outpatient clinics. |
| HQ Country | |
| HQ City | Sofia |
| Deal Date | 20 Oct 2015 |
| Valuation | $600K |
| EV/Revenue | |
| EV/EBITDA | |
This data is available for Pro users. Sign up to see all Apyx Medical acquisitions and their M&A valuation multiples. Start Free Trial | |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Apyx Medical
| When was Apyx Medical founded? | Apyx Medical was founded in 1982. |
| Where is Apyx Medical headquartered? | Apyx Medical is headquartered in United States. |
| How many employees does Apyx Medical have? | As of today, Apyx Medical has over 220 employees. |
| Who is the CEO of Apyx Medical? | Apyx Medical's CEO is Charles D. Goodwin. |
| Is Apyx Medical publicly listed? | Yes, Apyx Medical is a public company listed on Nasdaq. |
| What is the stock symbol of Apyx Medical? | Apyx Medical trades under APYX ticker. |
| When did Apyx Medical go public? | Apyx Medical went public in 1994. |
| Who are competitors of Apyx Medical? | Apyx Medical main competitors include Edap TMS, Sisram Medical, Inogen, Quanterix, NN, Aroa Biosurgery, EKF Diagnostics, Guerbet, CROSSJECT, Owlet. |
| What is the current market cap of Apyx Medical? | Apyx Medical's current market cap is $162M. |
| What is the current revenue of Apyx Medical? | Apyx Medical's last 12 months revenue is $56M. |
| What is the current revenue growth of Apyx Medical? | Apyx Medical revenue growth (NTM/LTM) is 12%. |
| What is the current EV/Revenue multiple of Apyx Medical? | Current revenue multiple of Apyx Medical is 3.1x. |
| Is Apyx Medical profitable? | No, Apyx Medical is not profitable. |
| What is the current EBITDA of Apyx Medical? | Apyx Medical has negative EBITDA and is not profitable. |
| What is Apyx Medical's EBITDA margin? | Apyx Medical's last 12 months EBITDA margin is (7%). |
| What is the current EV/EBITDA multiple of Apyx Medical? | Current EBITDA multiple of Apyx Medical is (43.5x). |
| What is the current FCF of Apyx Medical? | Apyx Medical's last 12 months FCF is ($10M). |
| What is Apyx Medical's FCF margin? | Apyx Medical's last 12 months FCF margin is (19%). |
| What is the current EV/FCF multiple of Apyx Medical? | Current FCF multiple of Apyx Medical is (16.5x). |
| How many companies Apyx Medical has acquired to date? | As of June 2026, Apyx Medical has acquired 1 company. |
| What was the largest acquisition by Apyx Medical? | $600K acquisition of Bovie Bulgaria EOOD on 20th October 2015 was the largest M&A Apyx Medical has done to date. |
| What companies Apyx Medical acquired? | Apyx Medical acquired Bovie Bulgaria EOOD. |
| In how many companies Apyx Medical has invested to date? | Apyx Medical hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Apyx Medical
Lists including Apyx Medical
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.
